Classification of the Myoclonic Epilepsies

Epilepsia

Volumn 44, Issue SUPPL. 11, 2003, Pages 2-6

  Leppik, Ilo E ^a  

^a MINCEP Epilepsy Care   (United States)

Author keywords

Classification; Epilepsy; Myoclonus; Seizures

Indexed keywords

CONFERENCE PAPER; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; EPILEPSY; GAUCHER DISEASE; HUMAN; MARKER GENE; MYOCLONUS EPILEPSY; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; PROGNOSIS; SIALIDOSIS;

EID: 0242659220     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.44.s11.4.x     Document Type: Conference Paper

References (29)

1. Serratosa JM. Myoclonic seizures. In: Wyllie E, ed. The treatment of epilepsy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:395-404.
2. Fahn S, Marsden CD, Van Woert MH. Definition and classification of myoclonus. Adv Neurol 1986;43:1-5.
3. Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth Scientific, 1985:198-248.
4. Hallett M. Myoclonus: relation to epilepsy. Epilepsia 1985;26(suppl 1):S67-77.
5. Guerrini R, Dravet C, Genton P, et al. Epileptic negative myoclonus. Neurology 1993;43:1078-83.
6. Commission on Pediatric Epilepsy of the International League Against Epilepsy. Myoclonus and epilepsy in childhood. Epilepsia 1997;38:1251-4.
7. Serratosa JM. The progressive myoclonus epilepsies. In: Wyllie E, ed. The treatment of epilepsy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:509-24.
8. Delgado-Escueta AV, Perez-Gosiengfiao KB, Bai D, et al. Recent development in the quest for myoclonic epilepsy genes. Epilepsia 2003;44:13-26.
9. Roger J, Genton C, Bureau M, et al. Progressive myoclonus epilepsies in childhood and adolescence. In: Roger J, Bureau M, Dravet C, et al, eds. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey, 1992:381-400.
10. Norio R, Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet 1979;15:382-98.
11. Mervaala E, Keranen T, Paakkonen A, Partanen JV, Riekkinen P. Visual evoked potentials, brainstem auditory evoked potentials, and quantitative EEG in Baltic progressive myoclonus epilepsy. Epilepsia 1986;27:542-7.
12. Cochius J, Carpenter S, Andermann E, et al. Sweat gland vacuoles in Unverricht-Lundborg disease: a clue to diagnosis? Neurology 1994;44:2372-5.
13. Pennacchio LA, Lehesjoki A-E, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-4.
14. Malafosse A, Lehesjoki AE, Genton P, et al. Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet 1992;339:1080-1.
15. Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ. "Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983;2:838-42.
16. Henry T, Leppik IE, Gumnit RJ, Jacobs M. Progressive myoclonus epilepsy treated with zonisamide. Neurology 1988;38:928-31.
17. Carpenter S, Karpati G. Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy. Neurology 1981;31:1564-8.
18. Zeman W, Donahue S, Dyken P, et al. The neuronal ceroidlipofuscinoses (Batten-Vogt syndrome). In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Vol 10. Amsterdam: North Holland, 1970:588-679.
19. Dyken PR. The neuronal ceroid lipofuscinoses. J Child Neurol 1989;4:165-74.
20. Berkovic SF, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). I. A clinical, pathological, biochemical, magnetic resonance spectographic and positron emission tomographic study. Brain 1989;112:1231-60.
21. Erikson A, Astrom M, Mansson JE. Enzyme infusion therapy of the norrbottnian (type 3) Gaucher disease. Neuropediatrics 1995;26:203-7.
22. Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982;32:798-807.
23. Burke JR, Enghild JJ, Martin ME, et al. Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-50.
24. Berkovic SF, Andermann F, Carpenter S, Wolfe LS. Progressive myoclonic epilepsies: specific causes and diagnosis. N Engl J Med 1986;315:296-305.
25. Andermann F, Andermann E, Carpenter S, et al. Action myoclonusrenal failure syndrome. In: Fahn S, Marsden C, Van Woert M, eds. Myoclonus. Advances in Neurology. Vol 43. New York: Raven Press, 1986:87-103.
26. Serratosa JM. Juvenile myoclonic epilepsy. In: Wyllie E, ed. The treatment of epilepsy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:491-508.
27. Elmslie FV, Rees M, Williamson KP, et al. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 1997;6:1329-34.
28. Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989;30(suppl 4):S19-23.
29. Genton P, Dravet C. Treatment of epilepsies with myoclonias. In: Shorvon S, Dreifuss F, Fish D, Thomas D, Reynolds E, eds. The treatment of epilepsy. Oxford: Blackwell Science, 1996:247-57.